These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37700218)

  • 1. Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers.
    Hatamikia S; Nougaret S; Panico C; Avesani G; Nero C; Boldrini L; Sala E; Woitek R
    Eur Radiol Exp; 2023 Sep; 7(1):50. PubMed ID: 37700218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration.
    Wei L; Niraula D; Gates EDH; Fu J; Luo Y; Nyflot MJ; Bowen SR; El Naqa IM; Cui S
    Br J Radiol; 2023 Oct; 96(1150):20230211. PubMed ID: 37660402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review.
    Prelaj A; Miskovic V; Zanitti M; Trovo F; Genova C; Viscardi G; Rebuzzi SE; Mazzeo L; Provenzano L; Kosta S; Favali M; Spagnoletti A; Castelo-Branco L; Dolezal J; Pearson AT; Lo Russo G; Proto C; Ganzinelli M; Giani C; Ambrosini E; Turajlic S; Au L; Koopman M; Delaloge S; Kather JN; de Braud F; Garassino MC; Pentheroudakis G; Spencer C; Pedrocchi ALG
    Ann Oncol; 2024 Jan; 35(1):29-65. PubMed ID: 37879443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery.
    Mikdadi D; O'Connell KA; Meacham PJ; Dugan MA; Ojiere MO; Carlson TB; Klenk JA
    Cancer Biomark; 2022; 33(2):173-184. PubMed ID: 35213360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiomics, artificial intelligence, and precision medicine in perinatology.
    Pammi M; Aghaeepour N; Neu J
    Pediatr Res; 2023 Jan; 93(2):308-315. PubMed ID: 35804156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
    Shrestha R; Llaurado Fernandez M; Dawson A; Hoenisch J; Volik S; Lin YY; Anderson S; Kim H; Haegert AM; Colborne S; Wong NKY; McConeghy B; Bell RH; Brahmbhatt S; Lee CH; DiMattia GE; Le Bihan S; Morin GB; Collins CC; Carey MS
    Cancer Res; 2021 Apr; 81(7):1681-1694. PubMed ID: 33441310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review).
    Wang Y; Lin W; Zhuang X; Wang X; He Y; Li L; Lyu G
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
    Li J; Li L; You P; Wei Y; Xu B
    Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer.
    Gottardo A; Russo TDB; Perez A; Bono M; Di Giovanni E; Di Marco E; Siino R; Bannera CF; Mujacic C; Vitale MC; Contino S; Iannì G; Busuito G; Iacono F; Incorvaia L; Badalamenti G; Galvano A; Russo A; Bazan V; Gristina V
    Cytopathology; 2024 Nov; 35(6):664-670. PubMed ID: 38822635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the novel immune and molecular signatures of ovarian cancer: insights and innovations from single-cell sequencing.
    Li Z; Gu H; Xu X; Tian Y; Huang X; Du Y
    Front Immunol; 2023; 14():1288027. PubMed ID: 38022625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances of Artificial Intelligence Application in Medical Imaging of Ovarian Cancers.
    Chen X; Huo XF; Wu Z; Lu JJ
    Chin Med Sci J; 2021 Sep; 36(3):196-203. PubMed ID: 34666872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel subtype to predict prognosis and treatment response with DNA driver methylation-transcription in ovarian cancer.
    Xu Z; Zhang L; Wang M; Huang Y; Zhang M; Li S; Wang L; Li K; Hou Y
    Epigenomics; 2022 Sep; 14(18):1073-1088. PubMed ID: 36200265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis.
    Kang W; Qiu X; Luo Y; Luo J; Liu Y; Xi J; Li X; Yang Z
    J Transl Med; 2023 Sep; 21(1):598. PubMed ID: 37674169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics in high-grade serous ovarian cancer: Biomarkers from genome to the immunome.
    Clifford C; Vitkin N; Nersesian S; Reid-Schachter G; Francis JA; Koti M
    Am J Reprod Immunol; 2018 Aug; 80(2):e12975. PubMed ID: 29781548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review.
    Parpinel G; Laudani ME; Piovano E; Zola P; Lecuru F
    Cancer Control; 2023; 30():10732748231159553. PubMed ID: 36847148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiomics, virtual reality and artificial intelligence in heart failure.
    Gladding PA; Loader S; Smith K; Zarate E; Green S; Villas-Boas S; Shepherd P; Kakadiya P; Hewitt W; Thorstensen E; Keven C; Coe M; Nakisa B; Vuong T; Rastgoo MN; Jüllig M; Starc V; Schlegel TT
    Future Cardiol; 2021 Nov; 17(8):1335-1347. PubMed ID: 34008412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System.
    He T; Huang L; Li J; Wang P; Zhang Z
    Front Med (Lausanne); 2021; 8():587496. PubMed ID: 34109184
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study.
    Torres-Martos Á; Anguita-Ruiz A; Bustos-Aibar M; Ramírez-Mena A; Arteaga M; Bueno G; Leis R; Aguilera CM; Alcalá R; Alcalá-Fdez J
    Artif Intell Med; 2024 Oct; 156():102962. PubMed ID: 39180924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the clinical utility of multi-omics data for predicting serous ovarian cancer prognosis.
    Zhang Z; Wei Z; Zhao L; Gu C; Meng Y
    J Obstet Gynaecol; 2023 Dec; 43(1):2171778. PubMed ID: 36803381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiomics tools for improved atherosclerotic cardiovascular disease management.
    Sopic M; Vilne B; Gerdts E; Trindade F; Uchida S; Khatib S; Wettinger SB; Devaux Y; Magni P;
    Trends Mol Med; 2023 Dec; 29(12):983-995. PubMed ID: 37806854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.